Abstract
In an in vitro pharmacodynamic model, a twice-daily cefdinir dosing regimen was more effective than a once-daily regimen against common bacterial respiratory pathogens in producing 3-log10 killing and preventing the occurrence of regrowth at 24 h. Twice-daily administration is likely the more appropriate cefdinir dosing strategy for the treatment of community-acquired pneumonia.
Original language | English (US) |
---|---|
Pages (from-to) | 2936-2938 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 45 |
Issue number | 10 |
DOIs | |
State | Published - 2001 |